Back to top
more

Cellebrite DI Ltd. (CLBT)

(Delayed Data from NSDQ)

$13.57 USD

13.57
988,574

-0.25 (-1.81%)

Updated Aug 8, 2025 03:59 PM ET

After-Market: $13.65 +0.08 (0.59%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.75%
2Buy17.82%
3Hold9.58%
4Sell5.28%
5Strong Sell2.61%
S&P50011.30%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

F Value B Growth C Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 36% (89 out of 244)

Industry: Internet - Software

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Sanghamitra Saha headshot

5 Under-$15 Stocks Wall Street Analysts Recommend Buying

by Sanghamitra Saha

After a stellar rally in Wall Street this year, investors with limited funds but desire to participate in the market can bet on low-priced top-ranked stocks like Eton Pharmaceuticals (ETON), LegalZoom.com (LZ), PLAYSTUDIOS (MYPS), American Public Education (APEI) and Cellebrite DI (CLBT).

Zacks Equity Research

Are Business Services Stocks Lagging Cellebrite DI Ltd. (CLBT) This Year?

by Zacks Equity Research

Here is how Cellebrite DI Ltd. (CLBT) and Core & Main (CNM) have performed compared to their sector so far this year.

Brian Bolan headshot

Cellebrite (CLBT) and LiveRamp (RAMP) Are Aggressive Growth Stocks

by Brian Bolan

Two more names for your aggressive growth stock radar screen.

Zacks Equity Research

Are You Looking for a Top Momentum Pick? Why Cellebrite DI Ltd. (CLBT) is a Great Choice

by Zacks Equity Research

Does Cellebrite DI Ltd. (CLBT) have what it takes to be a top stock pick for momentum investors? Let's find out.

Nilanjan Choudhury headshot

5 Solid Relative Price Strength Opportunities for Investors

by Nilanjan Choudhury

CLBT, BWAY, TAST, RCL and GIC are five stocks with explosive relative price strength.

Zacks Equity Research

Earnings Estimates Moving Higher for Cellebrite DI Ltd. (CLBT): Time to Buy?

by Zacks Equity Research

Cellebrite DI Ltd. (CLBT) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

Zacks Equity Research

Best Momentum Stocks to Buy for November 17th

by Zacks Equity Research

FINW, PGR and CLBT made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on November 17, 2023.

Shaun Pruitt headshot

These Small-Cap Stocks are a Highlight of This Week's Earnings Lineup

by Shaun Pruitt

This week's earnings lineup has been highlighted by quite a few small-cap stocks that have strengthening prospects after posting impressive quarterly results on Tuesday.

Zacks Equity Research

Is Cellebrite DI Ltd. (CLBT) Stock Outpacing Its Business Services Peers This Year?

by Zacks Equity Research

Here is how Cellebrite DI Ltd. (CLBT) and Futu Holdings Limited Sponsored ADR (FUTU) have performed compared to their sector so far this year.

Zacks Equity Research

Has Copart (CPRT) Outpaced Other Business Services Stocks This Year?

by Zacks Equity Research

Here is how Copart, Inc. (CPRT) and Cellebrite DI Ltd. (CLBT) have performed compared to their sector so far this year.

Zacks Equity Research

Paymentus Holdings, Inc. (PAY) Hit a 52 Week High, Can the Run Continue?

by Zacks Equity Research

Paymentus (PAY) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Zacks Equity Research

Cellebrite DI Ltd. (CLBT) Q2 Earnings and Revenues Top Estimates

by Zacks Equity Research

Cellebrite DI Ltd. (CLBT) delivered earnings and revenue surprises of 66.67% and 5.83%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Cellebrite DI Ltd. (CLBT) Q1 Earnings Match Estimates

by Zacks Equity Research

Cellebrite DI Ltd. (CLBT) delivered earnings and revenue surprises of 0% and 2.61%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

V2X (VVX) Q1 Earnings and Revenues Beat Estimates

by Zacks Equity Research

V2X (VVX) delivered earnings and revenue surprises of 23.08% and 7.04%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Does Cellebrite DI Ltd. (CLBT) Have the Potential to Rally 28.35% as Wall Street Analysts Expect?

by Zacks Equity Research

The consensus price target hints at a 28.4% upside potential for Cellebrite DI Ltd. (CLBT). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

Zacks Equity Research

VNT or CLBT: Which Is the Better Value Stock Right Now?

by Zacks Equity Research

VNT vs. CLBT: Which Stock Is the Better Value Option?

Zacks Equity Research

Cellebrite DI Ltd. (CLBT) Misses Q3 Earnings and Revenue Estimates

by Zacks Equity Research

Cellebrite DI Ltd. (CLBT) delivered earnings and revenue surprises of -66.67% and 1.82%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Sunlight Financial Holdings Inc. (SUNL) Reports Q3 Loss, Tops Revenue Estimates

by Zacks Equity Research

Sunlight Financial Holdings Inc. (SUNL) delivered earnings and revenue surprises of -6.67% and 25.53%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Mogo Inc (MOGO) Reports Q3 Loss, Misses Revenue Estimates

by Zacks Equity Research

Mogo Inc (MOGO) delivered earnings and revenue surprises of 20% and 2.72%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Boxlight Corporation (BOXL) Beats Q3 Earnings Estimates

by Zacks Equity Research

Boxlight Corporation (BOXL) delivered earnings and revenue surprises of 50% and 3.50%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Coursera (COUR) Reports Q3 Loss, Tops Revenue Estimates

by Zacks Equity Research

Coursera (COUR) delivered earnings and revenue surprises of 36.36% and 6.24%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

ShotSpotter (SSTI) Surges 3.6%: Is This an Indication of Further Gains?

by Zacks Equity Research

ShotSpotter (SSTI) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.

Zacks Equity Research

IQV vs. CLBT: Which Stock Is the Better Value Option?

by Zacks Equity Research

IQV vs. CLBT: Which Stock Is the Better Value Option?

Zacks Equity Research

VNT vs. CLBT: Which Stock Should Value Investors Buy Now?

by Zacks Equity Research

VNT vs. CLBT: Which Stock Is the Better Value Option?

Zacks Equity Research

BCOR or CLBT: Which Is the Better Value Stock Right Now?

by Zacks Equity Research

BCOR vs. CLBT: Which Stock Is the Better Value Option?